Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
WST > SEC Filings for WST > Form 8-K on 1-Aug-2013All Recent SEC Filings

Show all filings for WEST PHARMACEUTICAL SERVICES INC | Request a Trial to NEW EDGAR Online Pro



Results of Operations and Financial Condition, Regulation FD Dis

Item 2.02 Results of Operations and Financial Condition.

On August 1, 2013, West Pharmaceutical Services, Inc. (Company) issued a press release announcing its financial results for the second quarter ended June 30, 2013. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

The information set forth in "Item 2.02 Results of Operations and Financial Condition," including the exhibit referred to therein, is incorporated herein by reference.

A copy of the Company's presentation materials used during the call will be available for 30 days through the Investors link at the Company's website,, and is also attached hereto as Exhibit 99.2 and incorporated herein by reference.

The information included under Item 2.02 (including Exhibit 99.1 and 99.2) is being furnished pursuant to Item 2.02 and Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (Exchange Act) or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

Item 8.01 Other Events.

On August 1, 2013, the Company issued a press release announcing a two-for-one stock split and an increase in its regular, quarterly cash dividend to $0.20 per share on a pre-split basis. The stock split will be effected in the form of a 100% stock dividend which will be distributed on September 26, 2013 to shareholders of record as of the close of business on September 12, 2013.

The quarterly cash dividend will be paid on November 6, 2013 to shareholders of record as of October 23, 2013 and will be paid on a post-split basis at the rate of $0.10 per share.

The press release is attached hereto as Exhibit 99.3 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits Exhibit 99.1 West Pharmaceutical Services, Inc. Earnings Press Release, dated August 1, 2013.
Exhibit 99.2 West Pharmaceutical Services, Inc. Presentation Slides. Exhibit 99.3 West Pharmaceutical Services, Inc. Stock Split and Dividend Announcement, dated August 1, 2013.

  Add WST to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for WST - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.